$85B+ US diagnostics market
Diagnostics
Comprehensive contact intelligence across in-vitro diagnostics (IVD) manufacturers, point-of-care testing companies, imaging diagnostics firms, and diagnostic service providers. Target R&D leaders, commercial teams, and procurement decision-makers.
$85B+
US Market Size
Total diagnostics market 2024
1,200+
IVD Companies
In-vitro diagnostics manufacturers
180,000+
POC Testing Sites
Point-of-care locations
72,000+
Verified Contacts
In this segment
Market Overview
US Diagnostics Market Intelligence
The US diagnostics market exceeds $85 billion and is growing at 6.2% CAGR. In-vitro diagnostics (IVD) represents the largest subsegment, driven by immunoassay, molecular, and clinical chemistry testing. Point-of-care diagnostics is the fastest-growing area, accelerated by decentralization of testing and demand for rapid results.
Target VP Commercial at IVD manufacturers for partnership and distribution deals
Reach R&D directors for reagent and platform technology sales
Connect with regulatory affairs managers for compliance solutions
Identify marketing directors for co-marketing and channel programs
Database Coverage
72,000+
Verified contacts
4,500+
Companies profiled
Updated every 30 days
Key Roles Available
VP Commercial
R&D Director
Regulatory Affairs
Marketing Director
Sales Director
Contact Breakdown by Role
VP Commercial / Sales3,200+
R&D Director4,800+
Regulatory Affairs Manager2,900+
Marketing Director2,400+
Product Manager5,600+
Top States by Contact Volume
1California
8,400+2New Jersey
5,200+3Massachusetts
4,800+4New York
4,100+5Illinois
3,200+Coverage across all 50 US states + 45 countries
Explore More Segments
Access verified contacts across all 8 specialized lab verticals.